Announcement on behalf of Obigen to change its financial and accounting officer

1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development officer, internal audit officer, or designated and non-designated representatives): financial and accounting officer
2.Date of occurrence of the change:2023/05/26
3.Name, title, and resume of the previous position holder: Cherrie Yeh / Supervisor / Senior Specialist, OBI Pharma Inc.
4.Name, title, and resume of the new position holder: Kelly Lin / Director / Assistant Manager of Assurance Services, PwC
5.Type of change (please enter: ”resignation”, ”position adjustment”, ”dismissal”, ”retirement”, ”death” or ”new replacement”):position adjustment
6.Reason for the change:position adjustment
7.Effective date:2023/05/26
8.Any other matters that need to be specified: None